What is a DCF model?
A Discounted Cash Flow model is the foundational method of equity valuation. The DCF model answers a precise question: what is a company worth today, given the cash flows the company is expected to generate in the future, adjusted for the time value of money and the risk inherent in those cash flows?
The mechanics are straightforward. An analyst projects a company's free cash flow to firm (FCFF) — operating cash flow minus capital expenditure, adjusted for working capital changes — over a forecast period of five to ten years. Beyond the forecast period, the analysis collapses into a single figure called the terminal value, which represents the present value of all cash flows the company is expected to generate in perpetuity after the forecast window closes. Both the explicit forecast-period cash flows and the terminal value are then discounted back to today using the WACC. The sum of those discounted values is the DCF intrinsic value of the enterprise. Subtract net debt to arrive at equity intrinsic value per share.
Terminal Value (Gordon Growth) = FCF_final × (1 + g) / (WACC − g)
WACC = (E/V) × Re + (D/V) × Rd × (1 − Tax Rate)
Where: g = long-run terminal growth rate, Re = cost of equity (CAPM), Rd = cost of debt
Near-term FCF
Growth FCF
Late FCF
◀ Dominates output
Value (DCF)
The apparent simplicity of the formula conceals the majority of the analytical work. Every input — WACC, terminal growth rate, margin trajectory, capex intensity, tax rate — is an assumption. The DCF does not generate certainty. The DCF generates a structured framework for converting assumptions about the future into a present-value number, which can then be stress-tested against alternative scenarios. The discipline is not in running the model. The discipline is in stress-testing the assumptions and understanding which inputs the output is most sensitive to.
WACC: the discount rate that governs everything
The WACC is the rate at which future cash flows are discounted back to the present. A higher WACC compresses intrinsic value — it reflects a higher required return demanded by capital providers. A lower WACC inflates intrinsic value. Because WACC appears in every denominator of the DCF formula, and because the terminal value denominator is (WACC − g), small changes in WACC produce disproportionately large changes in output — particularly for long-duration, high-multiple equities.
WACC has two components. The cost of equity (Re) is typically estimated using the Capital Asset Pricing Model: Re = Risk-Free Rate + Beta × Equity Risk Premium. In April 2026, with US 10-year Treasury yields near 4.3%, a standard equity risk premium of 5.0–5.5%, and sector-adjusted betas, cost-of-equity estimates for US large-cap equities range from approximately 8% (low-beta defensives) to 12–14% (high-beta growth). The cost of debt (Rd) is straightforward — the after-tax yield on the company's outstanding debt. Blended, these produce a WACC that reflects the firm's actual capital structure.
"The DCF does not predict the future. It makes assumptions explicit — so they can be challenged."
Tech — High Multiple
Healthcare / Pharma
Defensives / Staples
WACC sensitivity is not uniform across sectors. For NVIDIA (NVDA) — a company whose intrinsic value is dominated by terminal-period assumptions about AI infrastructure adoption — a 1 percentage point increase in WACC reduces DCF intrinsic value by approximately 25%. The reason is mathematical: when terminal value represents 80%+ of total value, and when the terminal value denominator is (WACC − g), small numerator changes cascade. For Coca-Cola (KO), where near-term cash flows are stable and predictable and terminal value represents a smaller share of total value, a 1% WACC change moves intrinsic value by roughly 8–12%. This asymmetry is not a quirk — it is the structural argument for maintaining a larger margin of safety when valuing high-multiple growth equities.
Terminal value: the number that dominates the model
Terminal value is the largest number in most DCF models, and the number most analysts underestimate the sensitivity of. In a standard 10-year DCF applied to an S&P 500 company with a WACC of 9% and a terminal growth rate of 3%, terminal value will typically account for 65–75% of total enterprise value. For a fast-growing technology company valued at 30–35× forward earnings — implying significant growth expected beyond a 10-year horizon — terminal value's share can exceed 80%.
Two inputs govern terminal value magnitude. First, the terminal growth rate (g): the assumed perpetual growth rate of free cash flow beyond the forecast period. Setting g above the long-run nominal GDP growth rate of 3.5–4.5% is theoretically problematic — a company cannot grow faster than the economy in perpetuity without eventually becoming the economy. In practice, sell-side models routinely embed terminal growth rates of 3–5%, with the upper end reserved for structurally advantaged businesses. A 0.5 percentage point change in g — from 3.0% to 3.5% — changes terminal value by approximately 15–20% in most standard models, everything else held constant.
Second, the terminal EBIT margin or FCF margin assumption embedded in the terminal year's FCF. Analysts who extrapolate current margin trajectories without questioning whether those margins are normalised or cyclically elevated build structural errors into the terminal value that no sensitivity table will reveal — because the sensitivity is typically run around the WACC and g inputs, not the terminal margin. The private equity industry's entry-multiple discipline is a practical acknowledgement of this problem: buying at 7–8.5× EV/EBITDA versus the 11× peak valuations of 2021 implicitly reflects a lower DCF intrinsic value embedded in that exit multiple, with terminal margin assumptions baked into the denominator.
How P/E, EV/EBITDA, and P/B relate to the DCF
Every valuation multiple used in equity research — P/E, EV/EBITDA, P/B, EV/Sales — is a compressed algebraic expression of a full DCF model under specific, usually implicit, assumptions. Understanding the relationship between multiples and DCF mechanics is what separates superficial valuation commentary from genuine analytical insight.
The price-to-earnings (P/E) ratio is the most widely cited multiple. A P/E of 20× implies an earnings yield of 5%, which corresponds to a DCF where WACC is approximately 9–10% and the terminal growth rate is in the 4–5% range — the remainder being a blended present-value weight of nearer-term earnings. When NVIDIA (NVDA) traded at 35–40× forward earnings in early 2026, the embedded DCF assumptions required either a substantially elevated terminal growth rate, a structurally lower discount rate (perhaps justified by NVDA's near-monopoly in AI training silicon), or both. When those assumptions become harder to defend — as interest rates rise and AI-infrastructure capex narratives mature — the P/E compresses even without a change in near-term earnings, because the market is repricing the implicit DCF inputs.
The EV/EBITDA multiple is most useful for capital-intensive industries where depreciation is a real economic cost (energy, industrials, real estate) and where debt levels vary significantly across peers. EV/EBITDA can be derived from a DCF by making explicit assumptions about the conversion from EBITDA to FCF: capex intensity, working capital, tax rate, and depreciation relative to maintenance capex. A 7× EV/EBITDA implies a DCF intrinsic value under one set of conversion assumptions; an 11× multiple implies the same EBITDA generating meaningfully higher intrinsic value under more optimistic FCF conversion or lower WACC assumptions. The private equity entry multiple discipline — referenced across the PE research — is a practical application of this equivalence: compressed entry multiples mechanically expand the DCF return available to the buyer.
The price-to-book (P/B) ratio is best understood through the excess-return framework. A P/B of 1× implies the market believes the company will earn its cost of equity — no more, no less. A P/B above 1× implies the market expects ROE to exceed the cost of equity over time, generating surplus economic value that compounds above book value. The Gordon Growth Model relationship — P/B = (ROE − g) / (ke − g) — makes explicit that P/B is simply a DCF applied to book value rather than free cash flow. Banks and asset managers are primarily valued on P/B because book value is the relevant base for financial intermediaries, and because the FCF concept does not translate cleanly to financial firms.
DCF by sector: four different models for four different businesses
The standard two-stage FCFF DCF is not universally appropriate. Different sector economics require different modelling approaches, all of which share the same present-value logic but differ in what they discount and how they define the "cash flow" available to equity holders.
Margin of safety: converting DCF outputs into investment decisions
A DCF model produces a point estimate of intrinsic value. The margin of safety is the required discount to that point estimate before an investment is considered actionable. Benjamin Graham introduced the concept in Security Analysis (1934) as a buffer against estimation error — the recognition that every DCF input is uncertain, and that uncertainty compounds through the model to produce a range of plausible intrinsic values rather than a single true number.
The required margin of safety should be calibrated to the uncertainty of the DCF inputs. Stable defensive equities — Coca-Cola, Procter & Gamble, utilities — have narrow FCF forecasting ranges because revenues are contractual or habitual, capex is predictable, and management has decades of capital allocation track record. A 10–15% discount to DCF central estimate may provide adequate margin of safety for a KO or PG. High-multiple growth equities — NVIDIA, Meta, emerging biotechnology — carry wide DCF ranges because terminal value dominates, growth rates are uncertain, and competitive dynamics can shift quickly. For these equities, a 30–40% discount to DCF central estimate is not excessively conservative; it is the minimum required to compensate for model uncertainty.
Practically, the margin of safety functions as a buy-trigger within an equity research framework. An analyst may model NVIDIA at a central DCF intrinsic value of $1,200 per share in a 9% WACC, 3.5% terminal growth rate scenario. A 30% margin of safety sets the buy threshold at $840. The discipline is not in the number — the discipline is in maintaining the threshold regardless of market momentum, commentary, or the emotional pull of a stock that has recently performed well. The institutional advantage in equity valuation is not better information. The institutional advantage is the willingness to hold a price discipline when the market price diverges from the DCF-derived threshold in either direction.
Data appendix
| Sector | Examples | Typical WACC | Terminal g | TV Share of EV | Margin of Safety | Primary Method |
|---|
The table makes three things visible. First, upside scenarios are asymmetric — a 2% WACC compression (10% to 8%) at the base terminal growth rate produces +70% intrinsic value, while a 2% WACC increase produces only −25%. This asymmetry is structural, not accidental: it reflects the mathematics of the Gordon Growth terminal value formula. Second, the combination of low WACC and high terminal growth rates produces implausibly optimistic outputs — intrinsic values 178% above base at 8% WACC and 4.5% terminal growth — which is precisely why those combinations should be challenged as inputs rather than used to justify an investment. Third, the margin-of-safety logic becomes concrete: purchasing a high-multiple equity at a 30% discount to DCF base case provides protection against a 1% WACC increase and a 0.5% terminal growth rate reduction simultaneously — which represents a plausible adverse scenario, not an extreme one.
Conclusion
The DCF framework is not a valuation machine that produces correct answers. The DCF framework is an analytical discipline that makes assumptions explicit, makes sensitivity transparent, and converts judgements about the future into a structured present-value estimate that can be tested, challenged, and compared against market price. Every forward P/E, EV/EBITDA, and P/B multiple shown across the equity research pages on this site is an implicit DCF under stated assumptions — the DCF framework is the explanation of why those numbers matter and how they connect to intrinsic value.
The institutional advantage in equity valuation is not access to better information. The institutional advantage is the discipline to maintain a DCF-derived price threshold and a margin-of-safety requirement when the market price diverges — whether in the direction of excessive pessimism or excessive optimism. The DCF framework is the architecture that makes that discipline possible.
DCF Valuation — Questions Investors Ask
What is a DCF model and how does it calculate intrinsic value?
A Discounted Cash Flow (DCF) model calculates intrinsic value by projecting a company's free cash flows over a 5–10 year forecast period, then adding a terminal value that captures all cash flows beyond the forecast window — and discounting both back to today using the weighted average cost of capital (WACC). The formula is: Intrinsic Value = Σ(FCFt / (1+WACC)^t) + Terminal Value / (1+WACC)^n. Terminal value typically accounts for 60–80% of the total result, which is why WACC and terminal growth rate assumptions dominate DCF sensitivity analysis.
How does WACC affect a DCF valuation?
WACC is the discount rate applied to all future cash flows in a DCF model — a higher WACC compresses intrinsic value, a lower WACC inflates it. For high-multiple tech equities where terminal value dominates, a 1 percentage point increase in WACC typically reduces DCF intrinsic value by 20–30%. For NVIDIA specifically, a move from 9% to 10% WACC reduces intrinsic value by approximately 25%. Defensives with near-term, stable cash flows are far less WACC-sensitive — a 1% WACC change moves Coca-Cola's (KO) intrinsic value by roughly 8–12%, making WACC sensitivity a key differentiator between growth and value investments.
What is terminal value in a DCF model and why does it matter so much?
Terminal value (TV) represents the present value of all free cash flows beyond the explicit forecast period, calculated as TV = FCF_final × (1+g) / (WACC − g), where g is the long-run growth rate. Terminal value accounts for 60–80% of intrinsic value in most DCF models — meaning a 0.5 percentage point change in the terminal growth rate assumption can move valuation by 15–20%. For high-growth tech companies like NVIDIA (NVDA) and Microsoft (MSFT), terminal value dominance often exceeds 80% of enterprise value, which is why margin-of-safety requirements are correspondingly higher for these equities.
How do P/E, EV/EBITDA, and P/B ratios relate to a DCF model?
P/E, EV/EBITDA, and P/B multiples are algebraic shortcuts to DCF outputs under specific assumptions. A P/E of 20× implies a ~5% earnings yield — roughly equivalent to a DCF with a WACC of 9–10% and modest terminal growth. EV/EBITDA can be derived from a DCF by backing out EBITDA margins and capex assumptions. P/B is a proxy for excess-return models where ROE exceeds cost of equity. When equity pages show forward P/E or 7–8.5× EV/EBITDA entry multiples vs. 11× 2021 peaks, those multiples directly reflect changes in the DCF-implied discount rates and terminal growth expectations embedded in market price.
Why can't you use a standard DCF model for banks and financials like Blackstone or Goldman Sachs?
Standard DCF models cannot be applied to financial firms like Blackstone (BX), KKR, or Goldman Sachs (GS) because debt is an input to their business model rather than a financing choice — making free cash flow to firm (FCFF) and WACC conceptually ill-defined. Instead, financial firms are valued using the Dividend Discount Model (DDM), which discounts dividends or distributable earnings at cost of equity (typically 10–12%), or an excess-return model that computes the present value of ROE in excess of cost of equity applied to book value. Blackstone's distributable earnings per unit (DE/unit) is the operative cash flow metric — not EBITDA or FCFF.
How do you value pharmaceutical companies like Eli Lilly or J&J using DCF?
Pharmaceutical companies require a pipeline-adjusted sum-of-the-parts DCF that models each major drug asset individually with peak sales probability, phase-adjusted approval probability, launch timing, and patent expiry. Eli Lilly's (LLY) valuation is heavily weighted toward GLP-1 pipeline peak sales estimates of $40–60B by 2030 for tirzepatide. Patent cliffs create non-linear valuation breaks — generic entry can reduce a blockbuster's revenues by 80–90% within 24 months of exclusivity loss. Standard single-entity DCF models applied to pharma without explicit patent-cliff sensitivity produce materially misleading intrinsic value estimates.
What is margin of safety in DCF valuation and how large should it be?
Margin of safety is the discount to DCF intrinsic value at which an investor is willing to purchase an equity — it compensates for estimation error in WACC, growth rates, and FCF projections. For stable defensive equities (Coca-Cola KO, Procter & Gamble PG) with predictable FCF, a 10–15% discount to intrinsic value may suffice. For high-growth tech equities (NVDA, META) or speculative biotech with wide DCF ranges, the margin of safety should be 30–40% or more. The margin of safety converts a DCF from an academic exercise into an actionable investment discipline — it is the buffer that accounts for the fact that no DCF assumption is known with certainty.